Company Filing History:
Years Active: 2002-2003
Title: Maria Del Carmen Onrubia Miguel: Innovator in Pharmaceutical Chemistry
Introduction
Maria Del Carmen Onrubia Miguel is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for producing essential medications. With a total of 3 patents to his name, his work has had a considerable impact on the pharmaceutical industry.
Latest Patents
One of his latest patents is the "Non-hydrated gabapentine polymorph, production process and utilization for producing pharmaceutical grade gabapentine." This innovation involves preparing a non-hydrated gabapentin polymorph by drying an aqueous solution of gabapentin through spray drying or turbo-drying. This polymorph is crucial for the preparation of pharmaceutical-grade gabapentin, which is achieved by subjecting the polymorph to crystallization from solvents.
Another significant patent is the "Venlafaxine production process." This process outlines the preparation of venlafaxine and its physiologically acceptable addition salts. It consists of reacting a compound of general formula (II), where R is a C-C alkyl, aryl, aralkyl, or cycloalkyl group of 3 to 6 carbon atoms, with an organomagnesium compound of general formula (III). The process also includes the formation of a salt of the obtained venlafaxine by reacting it with a physiologically acceptable acid.
Career Highlights
Maria Del Carmen Onrubia Miguel is currently associated with Medichem, S.A., a company known for its focus on pharmaceutical development and production. His work at Medichem has allowed him to explore innovative solutions in drug formulation and production processes.
Collaborations
Throughout his career, he has collaborated with notable colleagues, including Jordi Bosch Lladó and Elias Molins Grau. These collaborations have further enriched his research and development efforts in the pharmaceutical sector.
Conclusion
Maria Del Carmen Onrubia Miguel stands out as a key figure in pharmaceutical innovation, with his patents contributing to the advancement of medication production processes. His work continues to influence the industry positively, showcasing the importance of innovation in healthcare.